logo

For the Inventor, By the Inventor

Cincinnati, OH, United States of America

J Martin Grisar

This inventor holds 34 USPTO granted patents, primarily in Cardiotonic Agents. Top assignees: Merrell Dow Pharmaceuticals, Richardson-Merrell Inc., Merrell Pharmaceuticals, Inc.. Active years: 1976-1998.

IDiyas Innovation Intelligence. (2026). Inventor Profile: J Martin Grisar. Retrieved from https://idiyas.com/inventor/j-martin-grisar

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 34

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 6

Forward Citations = 109(Granted Patents)


Location History:

  • Cincinnati, OH (US) (1976 - 1983)
  • Strasbourg, FR (1983 - 1984)
  • Wissembourg, FR (1985 - 1998)

Company Filing History:

goldMedal19 out of 455 
 
Merrell Dow Pharmaceuticals
 patents
silverMedal11 out of 167 
 
Richardson-Merrell Inc.
 patents
bronzeMedal3 out of 194 
 
Merrell Pharmaceuticals, Inc.
 patents
4. 1 out of 236 
 
Hoechst Marion Roussel
 patents

Years Active: 1976-1998

Loading Chart...
Areas of Expertise:
Cardiotonic Agents
Cardioprotective Agents
Ascorbic Acid Derivatives
Thiazolones
Hydrazide Derivatives
Lactamimide Inhibitors
Benzofuranols
Hypolipidemic Agents
Imidazole Derivatives
Tocopherol Analogs
Piperidine Derivatives
Antihypertensive Agents
34 patents (USPTO):Explore Patents
1. 5721233 - Derivatives of 2,3-dihydro benzofuranols (1998-02-24),
2. 5545660 - Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans (1996-08-13),
3. 5510373 - Cardioprotective agents (1996-04-23),
4. 5500444 - Cardioprotective tocopherol analogs (1996-03-19),
5. 5484810 - Tissue protective tocopherol analogs (1996-01-16),
6. 5270336 - Ascorbic acid derivatives (1993-12-14),
7. 5175188 - Ascorbic acid derivatives (1992-12-29),
8. 4927939 - Cardiotonic aroylthiazolones (1990-05-22),
9. 4868197 - Reducing reperfusion injury with (1989-09-19),
10. 4762849 - Cardiotonic alkanoylthiazolones (1988-08-09),
11. 4734422 - Cardiotonic aroylthiazolones and the use thereof (1988-03-29),
12. 4623651 - Cardiotonic heterocyclocarbonyl- and acetyl-thiazolones (1986-11-18),
13. 4560700 - Pyrrole-3-carboxylate cardiotonic agents (1985-12-24),
14. 4526981 - [1,2-Dihydro-4(5)-acyl-2-oxo-2H-imidazol-4(5)-yl] methyl nitrates (1985-07-02),
15. 4447619 - 4-Alkanoylimidazol-2-ones (1984-05-08),

Title: The Innovative Journey of J Martin Grisar

Introduction: J Martin Grisar is a pioneering inventor based in Cincinnati, Ohio, whose creative spirit and dedication to innovation have led to remarkable contributions in the field of patents and inventions.

Latest Patents: J Martin Grisar holds several patents in various industries, showcasing his versatility and ingenuity in developing groundbreaking solutions to complex problems. His recent patents focus on cutting-edge technologies that are shaping the future of different sectors.

Career Highlights: Throughout his illustrious career, J Martin Grisar has consistently pushed the boundaries of what is possible, earning a reputation as a visionary inventor. His work has not only transformed industries but has also improved the lives of many through innovative solutions.

Collaborations: J Martin Grisar has collaborated with leading companies, research institutions, and universities to bring his inventions to life. His ability to work effectively in multidisciplinary teams has been instrumental in the success of his projects, highlighting his strong collaborative spirit.

Conclusion: J Martin Grisar's passion for innovation, coupled with his relentless drive to create, has established him as a prominent figure in the world of inventions and patents. His remarkable journey continues to inspire aspiring inventors and showcases the power of creativity in shaping a better tomorrow.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…